Abstract:Insufficient hydrogen sulfide (H2S) has been implicated in Type 2 diabetic mellitus (T2DM) and hyperhomocysteinemia (HHcy)-related cardiovascular complications. We investigated the role of H2S in T2DM and HHcy-induced endothelial dysfunction in small mesenteric artery (SMA) of db/db mice fed a high methionine (HM) diet. HM diet (8 weeks) induced HHcy in both T2DM db/db mice and non-diabetic db/+ mice (total plasma Hcy: 48.4 and 31.3 µM, respectively), and aggravated the impaired endothelium-derived hyperpolarization factor (EDHF)-induced endothelium-dependent relaxation to acetylcholine (ACh), determined by the presence of eNOS inhibitor N(ω)-nitro-L-arginine methyl ester (L-NAME) and prostacyclin (PGI2) inhibitor indomethacin (INDO), in SMA from db/db mice but not that from db/+ mice. A non-selective Ca2+-active potassium channel (KCa) opener NS309 rescued T2DM/HHcy-impaired EDHF-mediated vascular relaxation to ACh. EDHF-induced relaxation to ACh was inhibited by a non-selective KCa blocker TEA and intermediate-conductance KCa blocker (IKCa) Tram-34, but not by small-conductance KCa (SKCa) blocker Apamin. HHcy potentiated the reduction of free sulfide, H2S and cystathionine γ-lyase protein, which converts L-cysteine to H2S, in SMA of db/db mice. Importantly, a stable H2S donor DATS diminished the enhanced O2- production in SMAs and lung endothelial cells of T2DM/HHcy mice. Antioxidant PEG-SOD and DATS improved T2DM/HHcy impaired relaxation to ACh. Moreover, HHcy increased hyperglycemia-induced IKCa tyrosine nitration in human micro-vascular endothelial cells. EDHF-induced vascular relaxation to L-cysteine was not altered, whereas such relaxation to NaHS was potentiated by HHcy in SMA of db/db mice which was abolished by ATP-sensitive potassium channel blocker Glycolamide but not by KCa blockers.CONCLUSIONS:Intermediate HHcy potentiated H2S reduction via CSE-downregulation in microvasculature of T2DM mice. H2S is justified as an EDHF. Insufficient H2S impaired EDHF-induced vascular relaxation via oxidative stress and IKCa inactivation in T2DM/HHcy mice. H2S therapy may be beneficial for prevention and treatment of micro-vascular complications in patients with T2DM and HHcy.

H2S Inhibits Hyperglycemia-Induced Intrarenal Renin-Angiotensin System Activation via Attenuation of Reactive Oxygen Species Generation

H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.

Rescue of Mesangial Cells from High Glucose-Induced Over-Proliferation and Extracellular Matrix Secretion by Hydrogen Sulfide.

Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-Induced Diabetic Rat Model.

Hydrogen Sulfide Replacement Therapy Protects the Vascular Endothelium in Hyperglycemia by Preserving Mitochondrial Function

Exogenous Hydrogen Sulfide Prevents SOD2 Degradation to Safeguard Renal Function in Diabetic Kidney Disease

GYY4137, a H2S donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes

Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy

Effect of Novel Gasotransmitter Hydrogen Sulfide on Renal Fibrosis and Connexins Expression in Diabetic Rats

Treatment with Hydrogen Sulfide Alleviates Streptozotocin-Induced Diabetic Retinopathy in Rats

Sodium hydrosulfide inhibiting endothelial cells injury and neutrophils activation via IL-8/CXCR2/ROS/NF-B axis in type 1 diabetes mellitus rat

Hydrogen Sulfide Treatment Promotes Glucose Uptake by Increasing Insulin Receptor Sensitivity and Ameliorates Kidney Lesions in Type 2 Diabetes.

Exogenous Hydrogen Sulfide Attenuates Diabetic Myocardial Injury Through Cardiac Mitochondrial Protection

Hydrogen Sulfide Induces Keap1 S-Sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis Via Nrf2 Activation

Hyperhomocysteinemia Potentiates Diabetes-Impaired EDHF-induced Vascular Relaxation: Role of Insufficient Hydrogen Sulfide

Hydrogen Sulfide: Recent Progression and Perspectives for the Treatment of Diabetic Nephropathy

Hydrogen Sulfide Inhibits High-Salt Diet-Induced Renal Oxidative Stress and Kidney Injury in Dahl Rats.

Glucose-Induced Decrease Of Cystathionine Beta-Synthase Mediates Renal Injuries

Hydrogen Sulfide Improves Endothelial Dysfunction in Hypertension by Activating Peroxisome Proliferator-Activated Receptor Delta/endothelial Nitric Oxide Synthase Signaling.

Hydrogen Sulfide Targets EGFR Cys797/Cys798 Residues to Induce Na(+)/K(+)-ATPase Endocytosis and Inhibition in Renal Tubular Epithelial Cells and Increase Sodium Excretion in Chronic Salt-Loaded Rats.

Hydrogen Sulfide Improves Myocardial Remodeling Via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.